Which of the following describes a moderate-intensity statin dose according to current guidelines?

The answer of Rosuvastatin 10 mg/day as a moderate-intensity statin dose aligns with the current cholesterol treatment guidelines established by major health organizations. Moderate-intensity statins are defined as doses that lower low-density lipoprotein (LDL) cholesterol levels by approximately 30% to 49%.

Rosuvastatin at 10 mg is recognized as a moderate-intensity dose because it effectively reduces LDL cholesterol within that target range. According to the American College of Cardiology/American Heart Association (ACC/AHA) guidelines, this specific dosage achieves the moderate-intensity threshold, making it suitable for patients who require LDL cholesterol lowering without the need for high-intensity statin therapy.

In contrast, while Pravastatin 20 mg/day, Atorvastatin 40 mg/day, and Lipitor 20 mg/day are mentioned, they represent different dosing categories. Pravastatin at 20 mg is considered a low-intensity statin dose, Atorvastatin 40 mg/day is generally classified as a high-intensity dose, and Lipitor, known as the brand name for Atorvastatin, does not differentiate in terms of dose classification.

Understanding these classifications is crucial for appropriately managing cholesterol levels and